Earlier this week, Israel’s Teva Pharmaceuticals (NasdaqGS: TEVA) said it will pay $40.5 billion for Allergan’s (NYSE: AGN) generic drugs unit, underscoring the notion that the healthcare sector remains white hot when it comes to mergers... (full story)
With the sector being the best performer in the S&P 500 this year, and by a healthy margin at that, there should be plenty of health care exchange traded funds making new highs.
That was not the case Wednesday when even as U.S. Stocks soared,... (full story)
Here is a look at the 25 best and 25 worst ETFs from the past trading week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as potential starting points for those... (full story)
Exchange traded funds track the performance of their underlying components. However, as the popularity of the investment vehicle grows, some ETFs are beginning to affect the performance of individual stocks.
According to S&P Capital IQ, ETFs... (full story)
This post Infographic: The Cybersecurity Boom appeared first on Daily Reckoning .
Jeff Desjardins explores the thrilling (and scary) prospects of cybercrime and cyberterrorism after a year full of high-profile cybersecurity incidents, including... (full story)
Smart Beta products have become increasingly popular over the past few years as a way to combine passive and active investing. As of December 2014, there were more than 700 smart beta exchange-traded products around the world, encompassing $529... (full story)
Developed international stocks and exchange traded funds are pulling ahead with the Eurozone strengthening on improved earnings and Japan finding support from domestic institutional investors.
In Europe, with the Greek debt woes dissipating,... (full story)
Emerging market stocks and related exchange traded funds have been unloved over past couple of years as developed markets outperformed. However, some are shifting back to the more attractively valued developing countries.
Over the past five years,... (full story)
This post Two Little Headlines and the End of Health Care appeared first on Daily Reckoning .
Dave Gonigam explores the end of health care as we know it. Plus: What if we paid for groceries the way we pay for health care? And: Can you keep your... (full story)
As the Affordable Care Act adds millions into the healthcare system, the increased demand for health products and services are supporting the momentum in healthcare-related exchange traded funds.
The healthcare sector has been among the best... (full story)
This post Why Everyone Is Wrong About Low Interest Rates appeared first on Daily Reckoning .
Bill Bonner reports on Hillary Clinton's relationship with environmentalists, capitalism, and interest rates...
The post Why Everyone Is Wrong About... (full story)
An unexpected dip in U.S. crude oil inventories helped fuel a surge in energy prices and commodity-related exchange traded funds Wednesday.
On Wednesday, the United States Oil Fund (NYSEArca: USO ) , which tracks West Texas Intermediate oil, was... (full story)
This post The Fleet of Autonomous Cars is Growing appeared first on Daily Reckoning .
The fleet of autonomous cars on the road is growing. Stephen Petranek has more on just how many autonomous cars are now registered in the state of California,... (full story)
Charles Hugh Smith - Daily Reckoning - Wed Jul 29, 10:13AM CDT
This post Currency Devaluation: The Crushing Vice of Price appeared first on Daily Reckoning .
Charles Hugh Smith reports the negative consequence of devaluation few mention: the skyrocketing cost of imports...
The post Currency Devaluation:... (full story)
This post Here’s How You Book Gains While the Stock Market Gets “Hammered” appeared first on Daily Reckoning .
To a trader, a hammer is an important candlestick formation. Here’s your down and dirty description: A hammer occurs... (full story)
Shark Tank’s Kevin O’Leary and Connor O’Brien shook the finance world when they launched their first ETF in July of 2015. Under the O’Shares Investments brand name, the ETF is sure to be a hit among dividend-focused, long-term investors. (full story)